Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Doximity, Inc. stock logo
DOCS
Doximity
$27.73
-0.1%
$25.68
$19.71
$36.29
$5.17B1.182.12 million shs1.54 million shs
TriMas Co. stock logo
TRS
TriMas
$26.62
-0.3%
$26.44
$22.59
$29.07
$1.08B0.71176,693 shs120,705 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Doximity, Inc. stock logo
DOCS
Doximity
-0.18%-0.32%+15.54%-1.14%-9.59%
TriMas Co. stock logo
TRS
TriMas
-0.30%-1.77%+3.22%+13.37%+5.18%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Doximity, Inc. stock logo
DOCS
Doximity
2.5836 of 5 stars
2.10.00.00.02.54.22.5
TriMas Co. stock logo
TRS
TriMas
4.6436 of 5 stars
3.52.01.71.73.73.31.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Doximity, Inc. stock logo
DOCS
Doximity
2.13
Hold$28.733.60% Upside
TriMas Co. stock logo
TRS
TriMas
3.00
Buy$40.0050.26% Upside

Current Analyst Ratings

Latest NFC, TRS, CURY, and DOCS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/17/2024
Doximity, Inc. stock logo
DOCS
Doximity
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
5/17/2024
Doximity, Inc. stock logo
DOCS
Doximity
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$28.00 ➝ $29.00
5/17/2024
Doximity, Inc. stock logo
DOCS
Doximity
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
5/1/2024
TriMas Co. stock logo
TRS
TriMas
BWS Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$40.00 ➝ $40.00
4/25/2024
Doximity, Inc. stock logo
DOCS
Doximity
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Neutral$25.00
4/23/2024
Doximity, Inc. stock logo
DOCS
Doximity
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingUnderweight ➝ Underweight$25.00 ➝ $25.00
4/2/2024
Doximity, Inc. stock logo
DOCS
Doximity
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingIn-Line ➝ In-Line$30.00
3/15/2024
Doximity, Inc. stock logo
DOCS
Doximity
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderweight ➝ Underweight$22.00 ➝ $25.00
(Data available from 6/1/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Doximity, Inc. stock logo
DOCS
Doximity
$475.42M10.88$0.92 per share30.09$4.83 per share5.74
TriMas Co. stock logo
TRS
TriMas
$893.55M1.21$2.86 per share9.32$16.53 per share1.61

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Doximity, Inc. stock logo
DOCS
Doximity
$147.58M$0.7238.5134.235.2331.04%17.44%14.85%8/13/2024 (Estimated)
TriMas Co. stock logo
TRS
TriMas
$40.36M$0.9727.4412.16N/A4.48%9.68%4.82%7/25/2024 (Estimated)

Latest NFC, TRS, CURY, and DOCS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2024Q1 2024
TriMas Co. stock logo
TRS
TriMas
$0.28$0.37+$0.09$0.62$220.60 million$227.10 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Doximity, Inc. stock logo
DOCS
Doximity
N/AN/AN/AN/AN/A
TriMas Co. stock logo
TRS
TriMas
$0.160.60%N/A16.49%N/A

Latest NFC, TRS, CURY, and DOCS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/23/2024
TriMas Co. stock logo
TRS
TriMas
Quarterly$0.040.61%5/6/20245/7/20245/14/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Doximity, Inc. stock logo
DOCS
Doximity
N/A
6.20
6.20
TriMas Co. stock logo
TRS
TriMas
0.63
2.73
1.41

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Doximity, Inc. stock logo
DOCS
Doximity
87.19%
TriMas Co. stock logo
TRS
TriMas
99.42%

Insider Ownership

CompanyInsider Ownership
Doximity, Inc. stock logo
DOCS
Doximity
39.40%
TriMas Co. stock logo
TRS
TriMas
1.10%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Doximity, Inc. stock logo
DOCS
Doximity
977186.55 million113.05 millionNot Optionable
TriMas Co. stock logo
TRS
TriMas
3,40040.73 million40.29 millionOptionable

NFC, TRS, CURY, and DOCS Headlines

Recent News About These Companies

TriMas Co. (NASDAQ:TRS) Short Interest Update
Herbert Parker Bought 55% More Shares In TriMas

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Doximity logo

Doximity

NASDAQ:DOCS
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
TriMas logo

TriMas

NASDAQ:TRS
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands. The Aerospace segment provides fasteners, collars, blind bolts, rivets, ducting, and connectors for air management systems, and other highly-machined parts and components to original equipment manufacturers, supply chain distributors, and tier one suppliers, as well as maintenance, repair and overhaul (MRO)/aftermarket providers; and military and defense aerospace applications and platforms under the Monogram Aerospace Fasteners, Allfast Fastening Systems, Mac Fasteners, TFI Aerospace, RSA Engineered Products, and Martinic Engineering brands. The Specialty Products segment offers steel cylinders for use in the transportation, storage, and dispensing of compressed gases under the Norris Cylinder brand; natural gas powered wellhead engines, compressors, and replacement parts for oil and natural gas production, and other industrial and commercial markets under the Arrow brand; and spare parts for various industrial engines. It sells its products through a direct sales force, third-party agents, and distributors. TriMas Corporation was incorporated in 1986 and is headquartered in Bloomfield Hills, Michigan.